Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology

Update vision on COVID-19: Structure, immune pathogenesis, treatment and safety assessment” - ScienceDirect

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review, Critical Care Medicine, JAMA

COVID-19, Radiology Reference Article

Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response

EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERTIES IN m RNA vaccine MANIFACTURING STRATEGY - STATE OF EVIDENCE

Impact Factor 5.085 - Citescore 5.4 More On Impact, PDF, Interferon

Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response

PDF) Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response

Frontiers Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response, Volume II

PDF) Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response

COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies

Catheter-Based Local Delivery of Therapeutics to the Lungs for Severe or Critically Ill Patients with COVID-19 - European Medical Journal

O que a ciência já sabe sobre antivirais para tratamento de Covid-19?

I study viruses: How our team isolated the new coronavirus to

Health risks can persist at least 2 years after COVID-19, new data

Home – CanCOVID

After Four Years, 59% in U.S. Say COVID-19 Pandemic Is Over

Covid: Why is coronavirus such a threat?